Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model

Journal of Gene Medicine

Volumn 10, Issue 9, 2008, Pages 951-964

  Moreno, Rafael ^a   Rosal, Marta ^b   Martinez, Itziar ^a   Vilardell, Felip ^c   Gonzalez, Juan Ramón ^d   Petriz, Jordi ^b   Hernandez Andrade, Edgard ^e   Gratacós, Eduard ^e   Aran, Josep M ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

EGFP expression; Fetal rabbit; Immune response; Lentiviral vector; PCR

Indexed keywords

CYTOKERATIN 5; ENHANCED GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BASAL CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENE EXPRESSION REGULATION; GENE TRANSFER; GESTATIONAL AGE; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INTERVENTION STUDY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; RABBIT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TRANSGENE; VIRUS ENVELOPE; VIRUS PARTICLE;

ANIMALS; FEMALE; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; LENTIVIRUS; MODELS, ANIMAL; PREGNANCY; RABBITS; STEM CELLS; TRANSGENES;

ANIMALIA; LENTIVIRUS; ORYCTOLAGUS CUNICULUS;

EID: 52649181650     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1227     Document Type: Article

References (56)

1. Bischoff FZ, Sinacori MK, Dang DD, et al. Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis. Hum Reprod Update 2002; 8: 493-500.
2. O'Brien B, Bianchi DW. Fetal therapy for single gene disorders. Clin Obstet Gynecol 2005; 48: 885-896.
3. Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002; 296: 2410-2413.
4. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185-1193.
5. Ott MG, Schmidt M, Schwarzwaelder K, et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006; 12: 401-409.
6. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419.
7. Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992; 11: 3053-3058.
8. Levine BL, Humeau LM, Boyer J, et al. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 2006; 103: 17372-17377.
9. Han XD, Lin C, Chang J, et al. Fetal gene therapy of alpha-thalassemia in a mouse model. Proc Natl Acad Sci USA 2007; 104: 9007-9011.
10. Seppen J, van der Rijt R, Looije N, et al. Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol Ther 2003; 8: 593-599.
11. Waddington SN, Nivsarkar MS, Mistry AR, et al. Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 2004; 104: 2714-2721.
12. Williams ML, Coleman JE, Haire SE, et al. Lentiviral expression of retinal guanylate cyclase-1 (RetGC1) restores vision in an avian model of childhood blindness. PLoS Med 2006; 3: E201.
13. Waddington SN, Kennea NL, Buckley SM, et al. Fetal and neonatal gene therapy: benefits and pitfalls. Gene Ther 2004; 11(Suppl 1): S92-S97.
14. Moreno R, Rosal M, Cabero L, et al. Feasibility of retroviral vector-mediated in utero gene transfer to the fetal rabbit. Fetal Diagn Ther 2005; 20: 485-493.
15. Salmon P, Kindler V, Ducrey O, et al. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 2000; 96: 3392-3398.
16. Klages N, Zufferey R. Trono DA stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther 2000; 2: 170-176.
17. Aran JM, Gottesman MM, Pastan I. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and beta-galactosidase or green fluorescent protein. Cancer Gene Ther 1998; 5: 195-206.
18. Beaudoin S, Barbet P, Bargy F. Developmental stages in the rabbit embryo: guidelines to choose an appropriate experimental model. Fetal Diagn Ther 2003; 18: 422-427.
19. Boyle MP, Enke RA, Adams RJ, et al. In utero AAV-mediated gene transfer to rabbit pulmonary epithelium. Mol Ther 2001; 4: 115-121.
20. Pinheiro J, Bates D. Mixed-Effects Models in S and S-PLUS. Springer-Verlag: New York, NY, 2000.
21. Stuckhardt JL, Brunden MN, Harris SB. Influence of intrauterine position on fetal weight in Dutch belted rabbits. J Toxicol Environ Health 1981; 8: 777-786.
22. Jimenez DF, Lee CI, O'Shea CE, et al. HIV-1-derived lentiviral vectors and fetal route of administration on transgene biodistribution and expression in rhesus monkeys. Gene Ther 2005; 12: 821-830.
23. Hong KU, Reynolds SD, Watkins S, et al. In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations. Am J Physiol Lung Cell Mol Physiol 2004; 286: L643-L649.
24. Coutelle C, Themis M, Waddington SN, et al. Gene therapy progress and prospects: fetal gene therapy - first proofs of concept - some adverse effects. Gene Ther 2005; 12: 1601-1607.
25. Waddington SN, Kramer MG, Hernandez-Alcoceba R, et al. In utero gene therapy: current challenges and perspectives. Mol Ther 2005; 11: 661-676.
26. Themis M, Waddington SN, Schmidt M, et al. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 2005; 12: 763-771.
27. Montini E, Cesana D, Schmidt M, et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 2006; 24: 687-696.
28. Lee CC, Jimenez DF, Kohn DB, et al. Fetal gene transfer using lentiviral vectors and the potential for germ cell transduction in rhesus monkeys (Macaca mulatta). Hum Gene Ther 2005; 16: 417-425.
29. Porada CD, Park PJ, Tellez J, et al. Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero. Mol Ther 2005; 12: 754-762.
30. Porada CD, Tran N, Eglitis M, et al. In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum Gene Ther 1998; 9: 1571-1585.
31. Cohen JC, Larson JE. Cystic fibrosis transmembrane conductance regulator (CFTR) dependent cytoskeletal tension during lung organogenesis. Dev Dyn 2006; 235: 2736-2748.
32. Ferrari S, Geddes DM, Alton EW. Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv Drug Deliv Rev 2002; 54: 1373-1393.
33. Waddington SN, Mitrophanous KA, Ellard FM, et al. Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice. Gene Ther 2003; 10: 1234-1240.
34. MacKenzie TC, Kobinger GP, Kootstra NA, et al. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther 2002; 6: 349-358.
35. Skarsgard ED, Huang L, Reebye SC, et al. Lentiviral vector-mediated, in vivo gene transfer to the tracheobronchial tree in fetal rabbits. J Pediatr Surg 2005; 40: 1817-1821.
36. Peebles D, Gregory LG, David A, et al. Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero. Gene Ther 2004; 11: 70-78.
37. Themis M, Schneider H, Kiserud T, et al. Successful expression of beta-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein. Gene Ther 1999; 6: 1239-1248.
38. Yang L, Bailey L, Baltimore D, et al. Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci USA 2006; 103: 11479-11484.
39. Galimi F, Saez E, Gall J, et al. Development of ecdysone-regulated lentiviral vectors. Mol Ther 2005; 11: 142-148.
40. Lois C, Hong EJ, Pease S, et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868-872.
41. Brovko LY, Griffiths MW. Illuminating cellular physiology: recent developments. Sci Prog 2007; 90: 129-160.
42. Borthwick DW, Shahbazian M, Krantz QT, et al. Evidence for stem-cell niches in the tracheal epithelium. Am J Respir Cell Mol Biol 2001; 24: 662-670.
43. Schoch KG, Lori A, Burns KA, et al. A subset of mouse tracheal epithelial basal cells generates large colonies in vitro. Am J Physiol Lung Cell Mol Physiol 2004; 286: L631-L642.
44. Johnson LG, Olsen JC, Naldini L, et al. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Ther 2000; 7: 568-574.
45. Adkins B, Williamson T, Guevara P, et al. Murine neonatal lymphocytes show rapid early cell cycle entry and cell division. J Immunol 2003; 170: 4548-4556.
46. Tran ND, Porada CD, Almeida-Porada G, et al. Induction of stable prenatal tolerance to beta-galactosidase by in utero, gene transfer into preimmune sheep fetuses. Blood 2001; 97: 3417-3423.
47. Waddington SN, Buckley SM, Nivsarkar M, et al. In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor. Blood 2003; 101: 1359-1366.
48. Zhang J, Xu L, Haskins ME, et al. Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs. Blood 2004; 103: 143-151.
49. Brown BD, Sitia G, Annoni A, et al. In vivo administration of lentiviral vectors triggers a type 1 interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 2007; 109: 2797-2805.
50. Annoni A, Battaglia M, Follenzi A, et al. The immune response to lentiviral-delivered transgene is modulated in vivo by transgene-expressing antigen-presenting cells but not by CD4 + CD25+ regulatory T cells. Blood 2007; 110: 1788-1796.
51. Follenzi A, Battaglia M, Lombardo A, et al. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 2004; 103: 3700-3709.
52. Pahal GS, Jauniaux E, Kinnon Q et al. Normal development of human fetal hematopoiesis between eight and 17 weeks' gestation. Am J Obstet Gynecol 2000; 183: 1029-1034.
53. Kamata Y, Tanabe A, Kanaji A, et al. Long-term normalization in the central nervous system, ocular manifestations, and skeletal deformities by a single systemic adenovirus injection into neonatal mice with mucopolysaccharidosis VII. Gene Ther 2003; 10: 406-414.
54. Holsapple MP, West LJ, Landreth KS. Species comparison of anatomical and functional immune system development. Birth Defects Res B Dev Reprod Toxicol 2003; 68: 321-334.
55. Seppen J, van Til NP, van der Rijt R, et al. Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats. Gene Ther 2006; 13: 672-677.
56. Brown BD, Venneri MA, Zingale A, et al. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 2006; 12: 585-591.